The following two reviews deal with the important topic of the physiology of amino acid metabolism in the maternal-placental-fetal unit. Dr. Jansson discusses the biology of amino acid transporters and Dr. Cetin reviews studies of amino acid transport and metabolism in experimental animals and humans. Recent work on the relation between abnormalities of amino acid transport and intrauterine growth retardation underline the importance of this topic and of these timely reviews.
Amino acid transport across the human placenta is active, mediated by specific transporters in syncytiotrophoblast plasma membranes. Using functional criteria such as substrate specificity and sodium dependence, approximately 15 transport systems have been identified in the human placenta. Recently, the area of molecular biology of amino acid transporters has evolved rapidly and at least 25 cDNA clones coding for mammalian amino acid transporters or transporter subunits have been identified. The primary objective of this review is to integrate the available functional data on placental amino acid transport systems with recent molecular information on mammalian amino acid transporters. Furthermore, models for the mechanisms for net materno-fetal transfer of amino acids are discussed. Finally, the evidence to suggest that alterations in placental amino acid transport systems may play a crucial role in the regulation of fetal growth are presented briefly. The plasma concentrations of most amino acids are higher in the fetus than in the mother (1) , suggesting an active transport of amino acids across the human placenta. There are only two cell layers positioned between the maternal and fetal circulation in the human placenta: the syncytiotrophoblast and the fetal capillary endothelium. The endothelium has been shown to be of the continuous type, closely resembling other continuous nonbrain capillaries (2) . This endothelial type allows for relatively unrestricted passage of amino acids through pores within the interendothelial cleft (3) and is therefore unlikely to represent a significant barrier to transport of amino acids. Instead, the transport across the polarized plasma membranes of the syncytiotrophoblast probably represents the limiting step in transplacental amino acid transfer. Consequently, isolated microvillous and basal syncytiotrophoblast membranes studied in vitro are particularly valuable experimental systems in elucidating the cellular mechanisms of amino acid transport across the placenta.
Amino acids are transported across plasma membranes mediated by transporter proteins. As a result of pioneer work some 50 years ago, in particular originating from Christensen et al. (4) , mammalian amino acid transport systems were identified and characterized according to functional criteria such as substrate specificity and sodium dependence. To date, approximately 15 transport systems have been identified in the human placenta using this functional classification. In 1990 the brain GABA transporter was the first mammalian amino acid transporter to be cloned and characterized (5) . Subsequently, the area of molecular biology of amino acid transporters has evolved rapidly (6, 7) , and, by employing a number of different strategies, at least 25 DNA sequences coding for mammalian amino acid transporters or transporter subunits have been identified (6) . In one of the most commonly used approaches, mRNA sequences of interest have been identified, e.g. by homology screening allowing the production of DNA sequences complementary to the mRNA (cDNA). To relate the cDNA to amino acid transport, cDNA may be functionally expressed, e.g. in oocytes, and the effect on amino acid transport is studied. If functional expression of the cDNA results in an increase in amino acid transport, the gene for an amino acid transporter, transporter regulator, or subunit may have been identified. In addition, the functional characteristics (Na ϩ -dependence, substrate specificity, affinity, etc.) of the amino acid transport may match a transport system previously identified in functional studies. The identification of genes coding for mammalian amino acid transporters will have a profound impact on the study of amino acid transport, allowing a more unequivocal classification of transporters and providing the tools for studies of transcriptional regulation as well as enabling the production of antibodies to transporter proteins.
Previously, amino acid transport in the human placenta has been the focus of a few excellent reviews (8 -11) . However, this paper will take advantage of the recent development in the molecular biology of mammalian amino acid transporters and integrate this information with available functional data on placental amino acid transport systems. Models for the mechanisms for net materno-fetal transfer of amino acids as well as the evidence to suggest that alterations in placental amino acid transport systems may play a crucial role in the regulation of fetal growth will be briefly discussed. Except where explicitly stated, this brief review is concerned with the human placenta.
PLACENTAL AMINO ACID TRANSPORTERS
The substrate specificity, distribution, and kinetic characteristics of the primary amino acid transporters shown to be present in the human syncytiotrophoblast are presented in Tables 1 and 2 .
Transport systems for neutral amino acids. At least five different transport systems for neutral amino acids have been identified in the human syncytiotrophoblast using villous tissue fragments (12) , in vitro perfused placenta (13) (14) (15) , and cultured trophoblast cells (16) and cell lines (17) as well as in plasma membrane vesicles (Table 1) . System A mediates the transport of zwitterionic amino acids with small side chains and has not yet been characterized at the molecular level (6) . System A activity is present both in the syncytiotrophoblast MVM and BM, however, the maximal transport capacity of the transporters is much higher in MVM (18, 19). Another Na ϩ -dependent transporter for neutral amino acids is system ASC, a transporter that appears to be localized in BM (19), although ASC activity has been demonstrated in MVM in some studies (20) but not in all (18, 21). At the molecular level, transporters with ASC-like activity are members of a superfamily of sodium-dependent transporters for anionic and neutral amino acids (6) . The clone ASCT1 is likely to represent the relevant cDNA for the human ASC transporter (22), however the expression of this gene appears to be very low in placenta (23). Therefore, it has been suggested that an as yet undefined ASC-like transporter might be responsible for the ASC activity in the placenta and liver (6) . In contrast, the human transcript ATB 0 , coding for the broad scope Na ϩ -dependent transporter B 0 , is highly expressed in the placenta (24). Cell lines of choriocarcinoma origin exhibit B 0 -like activity (25), but whether this activity is present in syncytiotrophoblast plasma membranes has not been addressed in detail (21, 26). The Na ϩ -dependent N system has recently been cloned and is primarily expressed in the liver (27). Some evidence suggests that system N-like activity might be present in human placental MVM (28), whereas other studies have failed to demonstrate this activity (29).
Taurine is a ␤-amino acid with a multitude of important physiologic functions, although it is not incorporated into proteins. The tissue concentration of taurine in human placenta is 100-to 200-fold higher than the concentration in maternal blood (1) , suggesting the presence of a highly efficient active transport of taurine across MVM. The transport system for ␤-amino acids in MVM has been studied thoroughly (30 -32). The Na ϩ -dependent taurine uptake in BM is only 6% of that of MVM (33), demonstrating that system ␤ is almost exclusively polarized to MVM. The human taurine transporter, TAUT, has been cloned from thyroid cells (34) and placenta (35) and has been found to be a member of the superfamily of sodium-and chloride-dependent neurotransmitter transporters (6) .
System L is a Na ϩ -independent transport system for neutral amino acids found in most mammalian cells, including syncytiotrophoblast MVM (18, 36) and BM (19, 26). Recently, two isoforms, LAT-1 (37) and LAT-2 (38, 39), of a subunit of the L transporter have been cloned and characterized. LAT form a heterodimeric complex with 4F2hc, a protein implicated in cationic amino acid transport. This heterodimer appears to be responsible for the L-type of transport activity. Both LAT-1 and LAT-2 mRNA are highly expressed in the placenta (37-39).
In addition to the transport systems for neutral amino acids discussed here, other transporters may be present in the syncytiotrophoblast as well. For example, the glycine transporter GLY might be present in MVM (40) . Furthermore, evidence from Kudo et al. suggest that several other amino acid transporters, yet to be fully characterized, are present in both MVM (21) and BM (26).
Transport systems for cationic amino acids. At least five different systems mediate transport of cationic amino acids in mammalian cells, three of which have been characterized at the molecular level (6) . Some controversy exists regarding which of these transporters are present in the syncytiotrophoblast membranes. However, it is well established that system y ϩ is the main transporter for cationic amino acids in MVM (41) (42) (43) (44) whereas y ϩ L represents the principal transport pathway across BM (43) (44) (45) . Furthermore, y ϩ L is also present in the MVM (41-44). System y ϩ is a Na ϩ -independent electrogenic transporter, which interacts only weakly with neutral amino acids 142 JANSSON and therefore is specific for cationic amino acids. In contrast, y ϩ L binds and transports neutral amino acids in the presence of sodium. The ecotropic murine leukemia virus receptor has been cloned and characterized as a cationic amino acid transporter (CAT-1) with y ϩ -like activity and widespread expression in human tissues, including the placenta (44, 46, 47) . Additional human y ϩ -like transporters have been cloned (CAT-2-4) and of these CAT-4 appears to be expressed on the mRNA level in the placenta (6) and might therefore contribute to placental y ϩ activity. Recently it was shown that CAT-1, -2B, and -4 is expressed in cultured trophoblast cells and in the BeWo choriocarcinoma cell line (48) , supporting the possibility that multiple members of the CAT family are expressed in the placenta in vivo. Expression of the gene for the heavy chain of the cell surface antigens (4F2hc) in oocytes results in a y ϩ L-like transport activity (49, 50) , and it was suggested that 4F2hc is a subunit or a regulator of the y ϩ L transporter. Indeed, 4F2hc mRNA is present in the human placenta and the protein appears to be expressed in MVM but not in BM (44) . More recently, y ϩ LAT, a membrane protein that associates with 4F2hc and mediates y ϩ L-like amino acid transport activity, was identified and characterized (51, 52) .
Some functional evidence has indicated that b, 0,ϩ activity is present in BM (45) , in contrast to the findings of other investigators (44) . In addition, Ayuk et al. were unable to demonstrate placental mRNA expression of rBAT (44) , the gene coding for b, 0,ϩ (53) . Another question that remains to be resolved is whether system y ϩ is present (41, 43) or not (44) in the syncytiotrophoblast basal membrane. When CAT-1 cRNA was injected into oocytes, the resulting y ϩ transport activity resembled the activity found in BM but not in MVM (48) , giving some support to the view that y ϩ activity is present in BM.
Transport systems for anionic amino acids. The anionic amino acids glutamate and aspartate are not transferred from mother to fetus in the perfused placenta in vitro (54) . Pioneer work in the sheep fetus has demonstrated that glutamate is produced from glutamine in the fetal liver (55) and subsequently taken up and metabolized by the placenta (56) . Indirect evidence such as a high degree of oxidation of glutamate to CO 2 in human trophoblast (57) and lack of net transfer of glutamate into the umbilical circulation from the placenta (58) suggest that anionic amino acids are handled in a similar fashion by the human placenta. Indeed, X -AG , a Na ϩ -and K ϩ -dependent transport system for anionic amino acids, is present in both plasma membranes of the syncytiotrophoblast (59 -61) . A family of five anionic amino acid transporters (EAAT1-5) have been cloned and, of these, EAAT 1-4 have been shown to be expressed on the mRNA level in the human placenta (62, 63) .
MECHANISMS FOR NET MATERNO-FETAL TRANSFER
This review concerns the primary amino acid transporter systems identified in the syncytiotrophoblast plasma membranes, and this information is clearly insufficient to completely analyze transplacental transport. Such analysis would require detailed information about transporter density per unit membrane area, surface areas of MVM and BM, concentrations of amino acids and ions in maternal, placental, and fetal compartments, placental metabolism of amino acids, and electrical driving forces in vivo. Furthermore, apart from the indirect evidence referred to in the introduction, the possible role of the endothelium in the transplacental transfer of amino acids remains to be elucidated. Some of this information is available. For example, MVM surface area has been estimated to be approximately sixfold larger than the area of BM (64), amino acid concentrations are quite well established (1), and membrane potentials have been measured in vitro (65) . In 143 membrane transport literature, the denominator mg membrane protein is assumed to represent membrane area. Although the validity of this assumption is difficult to test with certainty, MVM and BM isolated from human syncytiotrophoblast have similar phospholipid/protein ratio (66), lending some support for the validity of roughly comparing MVM and BM. Nevertheless, the following discussion on mechanisms of amino acid transport across the placenta will not take all these factors into account and will therefore represent a simplified model of in vivo processes. There is no net transfer of aspartate and glutamate across the human placenta (54) . Furthermore, there is a net uptake of serine by the placenta from the umbilical circulation in the fetal lamb (67) and it is possible that this apply also to human pregnancy. For most other amino acids there is a net transfer from the maternal to the fetal circulation. The mechanisms by which this vectorial transport is achieved remain to be fully established. However, available information is sufficient to allow the formulation of some general principles. First, by analogy with the intestinal epithelium (68), the unequal distribution of amino acid transporters to the two polarized plasma membranes of the syncytiotrophoblast represents the basic mechanism accounting for net transfer of amino acids to the fetus (9). Second, for most amino acids, placental concentrations are higher, sometimes much higher, than fetal plasma concentrations, which in turn are higher than maternal concentrations (1). This strongly suggests that the transport across MVM represents the active step in transplacental transfer, the nature of the driving force differing among different classes of amino acids. After being concentrated in the syncytiotrophoblast cell, amino acids diffuse down their concentration gradient into the fetal circulation as well as back to the mother. Net transport to the fetal compartment will result if the influx in greater than efflux in MVM and efflux is greater than influx across the BM.
For most neutral amino acids, Na ϩ -dependent transporter systems are available in the MVM (Table 1) , and the driving force for the accumulation of these amino acids in the syncytiotrophoblast cell is the Na ϩ -gradient across the MVM, ultimately dependent on the activity of Na ϩ /K ϩ -ATPase. Systems A and ␤, in particular, are highly polarized toward the MVM, providing the basis for net flux of neutral amino acids from the mother to the fetus (Fig. 1) . A strong candidate for exit pathway across the BM is system L, the broad-scope Na ϩ -independent transporter. The unspecific permeability of the basal membrane in vitro to neutral amino acids is not insignificant (19, 26, 43) probably due to high fluidity of this membrane (69) . It is therefore possible that nonmediated transport across the lipid bilayer of the BM might contribute to the exit of neutral amino acids from the syncytiotrophoblast cell. A Na ϩ -independent pathway for taurine transport has been identified in BM (33), however the exact nature of this pathway remains to be established. Taurine is not only an essential amino acid for normal fetal development but also plays an important role in syncytiotrophoblast volume regulation (70) . In response to a hyposmotic challenge, taurine is rapidly released from the cell through volume-activated channels. Whether these pathways also represent an exit pathway across BM and therefore are involved in transplacental taurine transport is currently unknown.
Some neutral amino acids appear not to be transported across the MVM by Na ϩ -dependent systems. This is particularly true for leucine, an amino acid that is transported mainly by the L system (43) . Therefore it is not immediately apparent what represents the driving force for uphill transport of leucine across the MVM. However, the L system exhibits strong trans-stimulation, i.e. the uptake of leucine is stimulated by a high intracellular concentration of another neutral amino acid (4). A possible candidate for driving the uptake of leucine is glycine (Fig. 2) , which is transported by system A and found in high concentrations in the placenta (1). Interestingly, in vivo studies suggest that although glycine is rapidly taken up by the placenta from the maternal circulation, transfer of this amino acid to the fetus is limited (71) . Although some of the glycine taken up by the placenta may be metabolized, the study of Cetin et al. also raises the possibility that glycine diffuses back into the maternal circulation. Because glycine is also accepted by the L system, glycine efflux might drive an uphill transport of leucine across MVM, a hypothesis that is supported by in vitro data (43) . The mechanisms responsible for the preferential efflux of leucine into the fetal circulation remain to be established but might be related to a substantial nonmediated transport of leucine across BM or a higher sensitivity of the MVM system L transporter for trans-stimulation. The syncytiotrophoblast cell interior is negative in relation to the outside, and potential difference has to be taken into account in the analysis of transport processes carrying net charge (i.e. electrogenic transporters). System A represents such a transporter carrying a net positive charge into the cell, the sodium gradient and the electrical potential both constituting the driving forces for uphill amino acid transport. The main transporter for cationic amino acids in the MVM is system y ϩ , a Na ϩ independent transporter carrying net positive charge. Therefore, the electrical potential difference provides the driving force for the transport of cationic amino acids against a concentration gradient across MVM (Fig. 3) . On the fetalfacing side of the syncytiotrophoblast cell, two driving forces with opposite directions will influence the flux of positively charged amino acids across BM: an outwardly directed con- Figure 1 . Mechanisms for transplacental transport: system A. Glycine is an example of a neutral amino acid transported by the Na ϩ -dependent system A and is concentrated in the syncytiotrophoblast energized by the Na ϩ gradient. Subsequently, glycine diffuses into the fetal circulation as well as back to the mother mediated by system L. The strong polarization of the system A transporter to MVM provides the basis for net transport to the fetus. Glycine concentrations in maternal and fetal plasma as well as in placental tissue were obtained from Boyd and Yudilevich (77). Mechanisms for transplacental transport: cationic amino acids. The uphill transport across MVM is driven by the negative charge inside the syncytium, mediated by system y ϩ , which is an electrogenic transporter. In contrast, the electroneutral system y ϩ L is the main transporter for cationic amino acids in BM. This transporter binds Na ϩ and a neutral amino acid mainly on the outside of the cell and performs exchange with cationic amino acids, thereby providing the driving force for efflux of cationic amino acids across BM. Lysine concentrations in maternal and fetal plasma as well as in placental tissue were obtained from Boyd and Yudilevich (77) . The transtrophoblast potential difference given in the figure was measured in mature intermediate villi by Greenwood et al. (65) and the actual value might therefore be somewhat different at the level of the exchange area.
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PLACENTAL AMINO ACID TRANSPORTERS centration gradient and an inwardly directed electrical gradient. The basis for a net efflux of cationic amino acids under these conditions is the polarization of the y ϩ L transporter to the BM. This transporter is not electrogenic because it binds Na ϩ and a neutral amino acid on one side of the plasma membrane and mediates exchange with a cationic amino acid (7) . Because extracellular Na ϩ concentrations are 10-fold higher than intracellular concentrations, the net transport of Na ϩ /neutral amino acid will be into the cell and direction of transport for cationic amino acid will be out of the cell.
PLACENTAL AMINO ACID TRANSPORT IN REGULATING FETAL GROWTH
Some evidence suggests that placental amino acid transport systems are specifically altered in pregnancy complications associated with restricted fetal growth (IUGR) (72) . IUGR remains an important obstetric and pediatric problem characterized in utero by a reduced fetal plasma concentration of a number of amino acids (58) . This pregnancy complication is associated with a marked decrease in the activity of system A in MVM (73) (74) (75) , whereas information about BM is less abundant (75) . Leucine uptake was shown to be decreased in both MVM and BM, whereas the uptake of lysine was reduced in BM only (43) . Furthermore, the activity of the taurine transporter is reduced in MVM in association with IUGR (33). In contrast to the effect of IUGR on these amino acid transporters, the activity and expression of syncytiotrophoblast glucose transporters remains unaltered (66) .
Insulin stimulates fetal growth and is secreted from the fetal endocrine pancreas in response to amino acids and glucose, providing a direct and efficient coupling between plasma concentrations of major nutrients and growth. It may be speculated that the down-regulation of placental amino acid transporter systems in IUGR results in decreased fetal plasma concentrations of certain amino acids, thereby contributing to the restricted fetal growth (33, 43). However, whether the observed changes in placental amino acid transporters represent a primary event in the pathophysiology of IUGR or is secondary to the growth restriction remains to be established.
Note added in proof:
Due to the rapid development in this area some additional amino acid transporters have been cloned and characterized since the preparation of this manuscript. Of particular interest to the field of placental amino acid transport is the recent molecular identification of two isoforms of the system A transporter in the rat (78, 79) and in the human (80, 81) . Both these isoforms, ATA1 and ATA2, have been shown to be expressed in the human placenta (80, 81) . activity of amino acid transport system L by phorbol esters and calmodulin antago- 
